352 related articles for article (PubMed ID: 36495325)
21. Comparison of [
Chen H; Pang Y; Li J; Kang F; Xu W; Meng T; Shang Q; Zhao J; Guan Y; Wu H; Xie F; Wang J; Sun L
Eur Radiol; 2023 Feb; 33(2):1329-1341. PubMed ID: 35976396
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
[TBL] [Abstract][Full Text] [Related]
23. Superiority of [
Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
[TBL] [Abstract][Full Text] [Related]
24. Comparison of [
Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
[TBL] [Abstract][Full Text] [Related]
25. First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
Wegen S; Roth KS; Weindler J; Claus K; Linde P; Trommer M; Akuamoa-Boateng D; van Heek L; Baues C; Schömig-Markiefka B; Schomäcker K; Fischer T; Drzezga A; Kobe C; Köhler C; Marnitz S
Clin Nucl Med; 2023 Feb; 48(2):150-155. PubMed ID: 36607364
[TBL] [Abstract][Full Text] [Related]
26. The performance of
Jiang Y; Wen B; Li C; Tian Y; Xiao Z; Xu K; Xing D; Yu Z; Huang J; Jia J; He Y
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2114-2126. PubMed ID: 36808001
[TBL] [Abstract][Full Text] [Related]
27. The 68 Ga-DOTA-FAPI-04 PET/CT for the differential diagnosis of solitary fibroma of pleura from other chest disease with low uptake of 18 F-FDG.
Zhang A; Meng X; Zhou X; Wang S; Zhang Y; Li N
Nucl Med Commun; 2022 Aug; 43(8):908-915. PubMed ID: 35551166
[TBL] [Abstract][Full Text] [Related]
28. The Added Value of
Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
[No Abstract] [Full Text] [Related]
29. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
30. Superior Tumor Detection for
Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the Relative Diagnostic Performance of [
Wu J; Wang Y; Liao T; Rao Z; Gong W; Ou L; Chen Y; Zhang C
Front Oncol; 2021; 11():737827. PubMed ID: 34604078
[TBL] [Abstract][Full Text] [Related]
32.
Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
[No Abstract] [Full Text] [Related]
33. Role of
Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
35. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
36. Comparison of [
Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
[TBL] [Abstract][Full Text] [Related]
38. Head‑to‑head assessment of [
Zhang A; Meng X; Yao Y; Zhou X; Zhang Y; Li N
Eur J Radiol; 2022 Oct; 155():110507. PubMed ID: 36075176
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study.
Kolodziej M; Saracyn M; Lubas A; Brodowska-Kania D; Mazurek A; Dziuk M; Dymus J; Kaminski G
Nucl Med Rev Cent East Eur; 2021; 24(2):63-69. PubMed ID: 34382670
[TBL] [Abstract][Full Text] [Related]
40. [
Zhang J; He Q; Jiang S; Li M; Xue H; Zhang D; Li S; Peng H; Liang J; Liu Z; Rao S; Wang J; Zhang R; Zhang L
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):937-950. PubMed ID: 36346437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
